- Home
- SILC vs ALEC Comparison
SILC vs ALEC Comparison
Compare SILC & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SILC | ALEC |
|---|---|---|
| Founded | 1987 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.6M | 275.8M |
| IPO Year | 2002 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SILC | ALEC |
|---|---|---|
| Price | $48.58 | $2.02 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 164.7K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $21,045,000.00 |
| Revenue This Year | $17.17 | $2.03 |
| Revenue Next Year | $12.28 | $29.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.34 | $1.09 |
| 52 Week High | $52.95 | $3.40 |
Technical Indicators
Market Signals| Indicator | SILC | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 60.80 | N/A |
| Support Level | $38.57 | N/A |
| Resistance Level | $52.52 | N/A |
| Average True Range (ATR) | 2.56 | 0.00 |
| MACD | 0.88 | 0.00 |
| Stochastic Oscillator | 86.45 | 0.00 |
Price Performance
Historical ComparisonAbout SILC Silicom Ltd
Silicom Ltd is engaged in designing, manufacturing, marketing, and supporting high-performance networking and data infrastructure solutions for a broad range of servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, Switches, Edge AI Solutions, Edge Networking Accessories, 4G 5G Products, FPGA-Based Cards, and Others. Its geographic areas are the USA, North America - other, Israel, Europe, and Asia-Pacific. It derives a majority of its revenue from the USA.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.